Inhibition of human immunodeficiency virus type 1 gp120 presentation to CD4 T cells by antibodies specific for the CD4 binding domain of gp120

Journal of Virology

Volumn 75, Issue 22, 2001, Pages 10950-10957

  Hioe, C E ^a   Tuen, M ^a   Chien P C , Jr ^a   Jones, G ^a   Ratto Kim, S ^a   Norris, P J ^a   Moretto, W J ^a   Nixon, D F ^a   Gorny, M K ^a   Zolla Pazner, S ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN GP 120;

ANTIBODY SPECIFICITY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; BINDING SITE; CELL ADHESION; COMPLEX FORMATION; GLYCOSYLATION; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE DEFICIENCY; LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROCESSING; T LYMPHOCYTE; VIRUS INHIBITION;

AIDS VACCINES; ANTIBODIES, MONOCLONAL; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD4; BINDING SITES; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; INTERFERON TYPE II;

EID: 0034764057     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.22.10950-10957.2001     Document Type: Article

References (37)

1. Control of antigen presentation by a single protease cleavage site
2. Lymphocyte proliferative responses to HIV-1 envelope and core antigens by infected and uninfected adults and children
3. A longitudinal study of neutralizing antibodies and disease progression in HIV-1-infected subjects
4. Inhibition of antigen-induced T-cell clone proliferation by antigen-specific antibodies
5. Priming of human CD4+ antigen-specific T cells to undergo apoptosis by HIV-infected monocytes. A two-step mechanism involving the gp120 molecule
6. Epitope-directed processing of specific antigen by B lymphocytes
7. Anti-CD4 binding domain antibodies complexed with HIV-1 gp120 inhibit CD4+ T cell proliferative responses to gp120
8. Neutralization of HIV-1 primary isolates by polyclonal and monoclonal human antibodies
9. Immunization with human immunodeficiency virus type 1 rgp120W61D in OS21/MPL adjuvant primes T cell proliferation and C-C chemokine production to multiple epitopes within variable and conserved domains of gp120W61D
10. Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection
11. Production of human monoclonal antibodies specific for conformational and linear non-V3 epitopes of gp120
12. Similarities and diversity among human monoclonal antibodies to the CD4-binding domain of HIV-1
13. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
14. Induction of specific T-cell responses in HIV infection
15. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: Correlation with CMV disease and effect of ganciclovir prophylaxis
16. Differential activation of T cell clones stimulated by macrophages exposed to antigen complexed with monoclonal antibodies. A possible influence of paratope specificity on the mode of antigen processing
17. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection
18. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals
19. Amino acid residues of the human immunodeficiency virus type 1 gp120 critical for the binding of rat and human neutralizing antibodies that block the gp120-sCD4 interaction
20. A CD4-independent interaction of human immunodeficiency virus-1 gp120 with CXCR4 induces their cointernalization, cell signaling, and T-cell chemotaxis
21. Early and persistent human immunodeficiency virus type 1 (HIV-1)-specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection
22. Antigen entry into early endosomes is insufficient for MHC class II processing
23. Role of the specific T-cell response for clearance and control of hepatitis C virus
24. HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression
25. HIV-specific lymphoproliferative responses in asymptomatic HIV-infected individuals
26. Establishment and characterization of human immunodeficiency virus type 1 (HIV-1) envelope-specific CD4+ T lymphocyte lines from HIV-1-seropositive patients
27. Recognition of HIV glycoprotein gp120 by T cells. Role of monocyte CD4 in the presentation of gp120
28. Analysis of host-virus interactions in AIDS with anti-gp120 T cell clones: Effect of HIV sequence variation and a mechanism for CD4+ cell depletion
29. Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants
30. CD4(+) T-lymphocyte depletion in human lymphoid tissue ex vivo is not induced by noninfectious human immunodeficiency virus type 1 virions
31. Simple enzyme immunoassay for titration of antibodies to the CD4-binding site of human immunodeficiency virus type 1 gp120
32. Improved cell-mediated immune responses in HIV-1-infected asymptomatic individuals after immunization with envelope glycoprotein gp160
33. Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection
34. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor
35. Suppressive effect of antibody on processing of T cell epitopes
36. The antigenic structure of the HIV gp120 envelope glycoprotein
37. Serotyping of primary human immunodeficiency virus type 1 isolates from diverse geographic locations by flow cytometry